Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS

Background: There is no clear consensus regarding the potential of denosumab for increasing the risk of infection in patients who concurrently receive biologic disease-modifying anti-rheumatic drugs (bDMARDs). In this study, we compared the rate of infection in postmenopausal women with rheumatoid a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaei, Alireza, Jahed, Seyed Adel, Amini Kadijani, Azade, Zabihiyeganeh, Mozhdeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111619/
https://www.ncbi.nlm.nih.gov/pubmed/33996663
http://dx.doi.org/10.47176/mjiri.35.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111619/
https://www.ncbi.nlm.nih.gov/pubmed/33996663
http://dx.doi.org/10.47176/mjiri.35.12

Ejemplares similares